DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $941,022 | +19.7% | 3,793 | +15.8% | 0.12% | +32.6% |
| Q2 2023 | $786,220 | +88.4% | 3,276 | +97.8% | 0.09% | +154.3% |
| Q1 2023 | $417,357 | -7.7% | 1,656 | -2.8% | 0.04% | -25.5% |
| Q4 2022 | $452,253 | +3.3% | 1,704 | +0.4% | 0.05% | 0.0% |
| Q3 2022 | $438,000 | +3.1% | 1,697 | +1.1% | 0.05% | +20.5% |
| Q2 2022 | $425,000 | -14.1% | 1,678 | -0.6% | 0.04% | -2.5% |
| Q1 2022 | $495,000 | +0.4% | 1,688 | +0.5% | 0.04% | +2.6% |
| Q4 2021 | $493,000 | -52.3% | 1,680 | -49.9% | 0.04% | -44.3% |
| Q3 2021 | $1,033,000 | +130.6% | 3,356 | +101.0% | 0.07% | +22.8% |
| Q2 2021 | $448,000 | +19.1% | 1,670 | 0.0% | 0.06% | -1.7% |
| Q1 2021 | $376,000 | -1.1% | 1,670 | +4.2% | 0.06% | -9.4% |
| Q4 2020 | $380,000 | +5.8% | 1,603 | +0.1% | 0.06% | -11.1% |
| Q3 2020 | $359,000 | +19.3% | 1,601 | +0.1% | 0.07% | +12.5% |
| Q2 2020 | $301,000 | +22.4% | 1,600 | 0.0% | 0.06% | +10.3% |
| Q1 2020 | $246,000 | -2.4% | 1,600 | -2.7% | 0.06% | +5.5% |
| Q4 2019 | $252,000 | +6.8% | 1,645 | +0.9% | 0.06% | -1.8% |
| Q3 2019 | $236,000 | – | 1,631 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |